4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-23-004092
Options or other derivatives
- Chief Financial Officer acquired 163,996 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gerber Brianna · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-15 | Grant or award : show line 1 in the form Employee Stock Options (right to buy) | +163,996 | 163,996 | D |
Loading xslF345X03/wf-form4_167667171935135.xml…